CASE INTELLIGENCE
SCHEDULE 13G - X4 Pharmaceuticals, Inc (0001501697) (Subject)
Filed
2026-09-21
2026-09-21
Document
REGULATORY_FILING
REGULATORY_FILING
Precedential status
UNKNOWN
UNKNOWN
Review score
15/100
15/100
Structured summary
SEC REGULATORY FILING Title: SCHEDULE 13G - X4 Pharmaceuticals, Inc (0001501697) (Subject) Link: https://www.sec.gov/Archives/edgar/data/1501697/000173804826000071/0001738048-26-000071-index.htm Ingested: 2026-09-22T01:00:17.195020+00:00
Disposition and provenance
Disposition: Not classified. Provenance hash: 655dd741aca9e81bcf64b2886cc3c2f78d88f5ce960423346a4c0d0b940efbab.
Review the official source record
Verification notice: Entity resolution and classification are automated. Verify names, dates, posture, and disposition against the linked official source. Lex Engine provides information infrastructure, not legal advice.